Literature DB >> 19646201

Glibenclamide treatment in relapsed transient neonatal diabetes as a result of a KCNJ11 activating mutation (N48D).

M Martín-Frías, E Colino, G Pérez de Nanclares, M Alonso, P Ros, R Barrio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646201     DOI: 10.1111/j.1464-5491.2009.02704.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  2 in total

1.  Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes.

Authors:  Maria Sara Remedi; Sophia E Agapova; Arpita K Vyas; Paul W Hruz; Colin G Nichols
Journal:  Diabetes       Date:  2011-08-03       Impact factor: 9.461

Review 2.  Genetics and pathophysiology of neonatal diabetes mellitus.

Authors:  Rochelle N Naylor; Siri Atma W Greeley; Graeme I Bell; Louis H Philipson
Journal:  J Diabetes Investig       Date:  2011-06-05       Impact factor: 4.232

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.